ORAL ESTRAMUSTINE PLUS ORAL ETOPOSIDE IN THE TREATMENT OF HORMONE-REFRACTORY PROSTATE CANCER PATIENTS: A PHASE II STUDY WITH A 5-YEAR FOLLOW-UP


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles